Navigation Links
Review of Nexavar Data Presented at ASCO 2007- Investor Conference,Call on June 4, 2007

Leverkusen, Germany, May 31, 2007- Results from various clinical studies including a pivotal Phase III trial in patients with advanced hepatocellular carcinoma, or primary liver cancer with Nexavar (sorafenib) tablets will be presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, USA from June 1 - 5, 2007.

On this occasion a conference call for investors and analysts will be held on June 4, 2007. Starting at around 2:00 p.m. CEST (12:00 noon GMT) live on the Internet, Bayer AG will be broadcasting the speech and discussion of the Investor Conference Call.

A recording of the conference call will be available as from 6:30 p.m. CEST (4:30 p.m. GMT).

The audio transmission and recording can be accessed on these sites:

English: http://www.investor.bayer.com German: http://www.investor.bayer.de

Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com

If you have any questions, please contact:

Dr. Alexander Rosar (+49-214-30-81013) Dr. Juergen Beunink (+49-214-30-65742) Peter Dahlhoff (+49-214-30-33022) Ilia Kürten (+49-214-30-35426) Ute Menke (+49-214-30-33021) Judith Nestmann (+49-214-30-66836) Dr. Olaf Weber (+49-214-30-33567)


'"/>




Page: 1

Related medicine technology :

1. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
2. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
3. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
4. Medicures MEND-CABG Trial Results Published in Peer Reviewed Journal
5. Reatas Synthetic Triterpenoids Profiled in Nature Reviews Cancer
6. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
7. Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified which Prevent Clear Interpretation of Results
8. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Review Nexavar Data Presented ASCO Investor Conference Call June
(Date:6/29/2015)... 29, 2015 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Proceedings of the National Academy of Sciences ... Company,s proprietary VelociGene ® and VelocImmune ® ... validation of potential candidates that could be developed ... Respiratory Syndrome (MERS). This involved the development of ...
(Date:6/29/2015)... According to a new market research report "Tumor ... of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone ... MarketsandMarkets, the global Tumor Ablation Market Is Poised to Reach ... from 2015 to 2020. Browse 72 market ... igures spread through 330 P ages and ...
(Date:6/29/2015)... 29, 2015 Henry Schein , ... of health care products and services to office-based ... that it has been selected as the Corporation ... Healthcare Executives (AHHE), a national voluntary tax-exempt organization ... presence of Hispanic health care executives. ...
Breaking Medicine Technology:Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5Tumor Ablation Market Worth $515.2 Million by 2020 2Tumor Ablation Market Worth $515.2 Million by 2020 3Tumor Ablation Market Worth $515.2 Million by 2020 4Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 2Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 3Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 4Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 5Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 6
(Date:6/30/2015)... ... 30, 2015 , ... Medflow, the leader in the ophthalmic ... records system from the company exclusively dedicated to helping eye care professionals for ... state-of-the-art solution combining modern cloud technology with Medflow’s proven expertise in the eye ...
(Date:6/30/2015)... ... June 30, 2015 , ... “It is never too ... SunGrubbies.com. “We are particularly interested in getting the word out to children because ... surface. We are extremely pleased with our new video which we feel ...
(Date:6/29/2015)... ... June 30, 2015 , ... The United States ... Team (KORT) as it becomes the Official Physical and Occupational Therapists of the U.S. ... Rolex Kentucky Three-Day Event presented by Land Rover. , “The USEF is pleased ...
(Date:6/29/2015)... ... June 29, 2015 , ... An upcoming documentary for public ... Earl Jones will offer a fresh perspective on conflict in sports with guest ... one of several thought leaders from around the sports industry that will discuss challenges ...
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, one of Southern ... their newest FAA-certified medical examiner in the city of Colton . , ... seeking to obtain their physical aviation certificates. Pilots hoping to navigate airplanes, helicopters, ...
Breaking Medicine News(10 mins):Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 2Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 3Health News:Healthpointe Now Offering FAA Physical Exams in San Bernardino County 2
... By Serena Gordon HealthDay Reporter , WEDNESDAY, Feb. ... called GAD-alum to treat type 1 diabetes failed to show ... sugar disease. The researchers, however, said they felt there ... and that specific groups of people still might benefit from ...
... Feb. 2 (HealthDay News) -- ,Greater use of certain types ... explain why black children,s risk of ischemic stroke dropped significantly ... in stroke-related deaths between black and white children also fell ... 74 percent more likely to die of ischemic stroke than ...
... By Alan Mozes HealthDay Reporter , THURSDAY, ... are exposed to might play a part in determining your ... about how sun may be bad for us, in terms ... an associate professor of biostatistics at the University of Alabama ...
... is associated with a loss of alcohol,s protective effect against ... increase of coronary risk among binge drinkers. ... the Danish National Cohort Study in 1994, 2000, and 2005 ... of IHD or all-cause mortality among "light-to-moderate" drinkers: (up to ...
... Mayo Clinic researchers have found that multiple exposures to ... rates of attention-deficit/hyperactivity disorder (ADHD) . Children exposed ... than double the incidence of ADHD than children who had ... Clinic pediatric anesthesiologist and investigator on the observational study. ...
... , WEDNESDAY, Feb. 1 (HealthDay News) -- ... good, it reduces inflammation in muscles at the cellular ... promote the growth of new mitochondria in skeletal muscle. ... the Buck Institute for Research on Aging and McMaster ...
Cached Medicine News:Health News:Type 1 Diabetes Treatment Disappoints in Trial 2Health News:Type 1 Diabetes Treatment Disappoints in Trial 3Health News:Efforts to Reduce Stroke in Kids With Sickle Cell Working: Study 2Health News:Lack of Sunlight May Raise Stroke Risk 2Health News:The effect of occasional binge drinking on heart disease and mortality among moderate drinkers 2Health News:Young children exposed to anesthesia multiple times show elevated rates of ADHD 2Health News:Science Shows How Massage Eases Sore Muscles 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: